News

Novo Nordisk pays $58.7m to settle claims of mis-selling liraglutide

BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j4214 (Published 08 September 2017) Cite this as: BMJ 2017;358:j4214

Re: Novo Nordisk pays $58.7m to settle claims of mis-selling liraglutide

This paper was originally published with the sentence:

"sales of liraglutide, which totalled $843bn last year. "

It should read:

"sales of liraglutide, which totalled $843m last year."

Thank you to Shyan Goh for pointing this out. We apologise for any confusion caused.

Competing interests: No competing interests

22 September 2017
Nicole Poulin
The BMJ
London, UK